Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Sintx Technologies, Inc. (SINT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.2700-0.0600 (-4.51%)
At close: 4:00PM EDT
1.2700 0.00 (0.00%)
After hours: 06:54PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.3300
Open1.3200
Bid1.2700 x 3200
Ask1.3300 x 1000
Day's Range1.2650 - 1.3296
52 Week Range1.2200 - 3.4400
Volume97,366
Avg. Volume1,274,772
Market Cap31.373M
Beta (5Y Monthly)2.11
PE Ratio (TTM)N/A
EPS (TTM)-0.4740
Earnings DateNov 15, 2021 - Nov 19, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.63
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SINT

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • SiNtx Technologies, Inc.
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total sales are generated in the United States.
    Rating
    Fair Value
    Economic Moat
    5 days agoMorningstar
View more
  • GlobeNewswire

    SINTX Technologies Shares Q3 2021 Revenue Update

    SALT LAKE CITY, Oct. 14, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, announced today preliminary Q3 2021 revenue results and expectation of new Q4 2021 revenue from open orders of advanced ceramics prototypes. Estimated revenue in Q3 2021 was approximately $240k which is more than the revenue in each of Q1 and Q2 2021. Revenue came from three business areas, including monolit

  • GlobeNewswire

    SINTX Technologies Ships New FleX SN Porous and Laser-textured Spinal Implants

    SINTX Technologies, Inc. An example of a porous and textured Flex SN surface. SALT LAKE CITY, Oct. 06, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, announced today that it has shipped production quantities of a new porous, laser-textured monolithic silicon nitride implant made of FleX SN (sintx.com/materials/flex) to be used in surgical spinal solutions. The shipment is the re

  • GlobeNewswire

    National Institute of Health Awards SINTX Technologies Phase 1 Grant for SN-PEEK 3D Printed Spinal Implants

    SALT LAKE CITY, Sept. 22, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, announced today a Phase 1 grant of $308,301 awarded by the National Institute of Health (NIH) to develop a 3-D printed, composite silicon nitride – polyetheretherketone (SN-PEEK) spinal implant. This U.S. government funded research grant addresses the antibacterial and osseointegrative properties of silicon

Advertisement
Advertisement